Literature DB >> 8866495

Characteristics of individuals with Huntington disease in long-term care.

M A Nance1, G Sanders.   

Abstract

This is a retrospective review of 97 Huntington disease (HD) patients living in long-term care facilities in the Twin Cities. The purpose of the study was to describe the demographic features, patterns of behavior, weight change, nursing issues, medication use, and hospitalization in this population. On admission to the nursing home, the "average" HD patient was of either sex, 45 years old, previously employed, a high school graduate, and not married. One third had severe behavior problems. Half gained and half lost weight; weight loss was not a predictor of death. Almost all used central nervous system-active drugs, most commonly neuroleptics. Eighty-four percent were ambulatory on admission, but 88% of those who died were nonambulatory at the time of death. We concluded that (a) HD patients are demographically different from other residents of long-term care facilities, (b) weight gain can occur in some late-stage patients, (c) negative behavior is a significant problem but is restricted to a subset of patients, and (d) adapting creatively to increasing multifaceted disability is the greatest challenge to the staff in facilities caring for HD patients.

Entities:  

Mesh:

Year:  1996        PMID: 8866495     DOI: 10.1002/mds.870110509

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  17 in total

Review 1.  Therapy in Huntington's disease: where are we?

Authors:  Martha A Nance
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

2.  Modeling Huntington's disease in cells, flies, and mice.

Authors:  S Sipione; E Cattaneo
Journal:  Mol Neurobiol       Date:  2001-02       Impact factor: 5.590

3.  Organoselenium bis selenide attenuates 3-nitropropionic acid-induced neurotoxicity in rats.

Authors:  Cristiani F Bortolatto; Cristiano R Jesse; Ethel A Wilhelm; Pietro M Chagas; Cristina W Nogueira
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

4.  A new measure for end of life planning, preparation, and preferences in Huntington disease: HDQLIFE end of life planning.

Authors:  Noelle E Carlozzi; E A Hahn; S A Frank; J S Perlmutter; N D Downing; M K McCormack; S Barton; M A Nance; S G Schilling
Journal:  J Neurol       Date:  2017-11-15       Impact factor: 4.849

Review 5.  An overview of psychiatric symptoms in Huntington's disease.

Authors:  K E Anderson; K S Marder
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

Review 6.  Determinants of functional disability in Huntington's disease: role of cognitive and motor dysfunction.

Authors:  Christopher A Ross; Alex Pantelyat; Jane Kogan; Jason Brandt
Journal:  Mov Disord       Date:  2014-09-15       Impact factor: 10.338

7.  Non-motor symptoms in Huntington's disease: a comparative study with Parkinson's disease.

Authors:  Tatiana Aldaz; Pasquale Nigro; Almudena Sánchez-Gómez; Celia Painous; Lluís Planellas; Pilar Santacruz; Ana Cámara; Yaroslau Compta; Francesc Valldeoriola; Maria J Martí; Esteban Muñoz
Journal:  J Neurol       Date:  2019-03-05       Impact factor: 4.849

8.  No evidence of impaired gastric emptying in early Huntington's Disease.

Authors:  Carsten Saft; Jürgen Andrich; Marc Fälker; Sarah Gauda; Sina Küchler; Dirk Woitalla; Oliver Goetze
Journal:  PLoS Curr       Date:  2011-10-25

9.  A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington's Disease.

Authors:  Eirini Kalliolia; Edina Silajdžić; Rajasree Nambron; Seán J Costelloe; Nicholas G Martin; Nathan R Hill; Chris Frost; Hilary C Watt; Peter Hindmarsh; Maria Björkqvist; Thomas T Warner
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

10.  Factors Associated with Low Body Mass Index in Huntington's Disease: A Spanish Multicenter Study of the European Huntington's Disease Registry.

Authors:  Esther Cubo; Jessica Rivadeneyra; Natividad Mariscal; Asunción Martinez; Diana Armesto; Rafael J Camara
Journal:  Mov Disord Clin Pract       Date:  2016-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.